Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TTR | P02766 | 2/20 | 0.36 |
| ▸ | ALB | P02768 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | VCAM1 | P19320 | 2/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.31 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.30 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16955503 | 0.87 | TSHR (0.31) | TSHRTTRALBMEN1KMT2A | |
| SCHEMBL27739 | 0.83 | — | — | |
| SCHEMBL1978513 | 0.83 | TTR (0.32) | TTRALBCYP2A6ALDH1A1 | |
| SCHEMBL16954619 | 0.81 | — | — | |
| SCHEMBL1978751 | 0.81 | — | — | |
| SCHEMBL352200 | 0.81 | — | — | |
| SCHEMBL16953840 | 0.81 | — | — | |
| SCHEMBL16950987 | 0.81 | FFAR4 (0.32) | TTRALBCYP2A6ALDH1A1 | |
| SCHEMBL3335656 | 0.79 | LOXL2 (0.35) | CYP2A6LOXL2 | |
| SCHEMBL60145 | 0.78 | TTR (0.50) | TSHRTTRALBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 575 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4146643-B1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AG (DE) | 2024-05-29 | — | — | EP | claimed |
| US-20230348432-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-11-02 | — | — | US | claimed |
| US-20230295162-A1 | SYNTHESIS OF NOVEL IMIPRIDONE DERIVATIVES AND THEIR EVALUATION FOR THEIR ANTICANCER ACTIVITY | SEMMELWEIS EGYETEM (HU) | 2023-09-21 | — | — | US | claimed |
| CN-116437925-A | Synthesis of novel elmidone derivatives and evaluation of anticancer activity thereof | 厄特沃什罗兰科技大学 | 2023-07-14 | — | — | CN | claimed |
| EP-4192467-A1 | SYNTHESIS OF NOVEL IMIPRIDONE DERIVATIVES AND THEIR EVALUATION FOR THEIR ANTICANCER ACTIVITY | Eötvös Loránd Tudományegyetem (HU) | 2023-06-14 | — | — | EP | claimed |
| US-20230149414-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. | 2023-05-18 | — | — | US | claimed |
| CN-115996639-A | Novel heteroaryl-triazole compounds as pesticides | 拜耳公司 | 2023-04-21 | — | — | CN | claimed |
| EP-4146643-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | Bayer Aktiengesellschaft (DE) | 2023-03-15 | — | — | EP | claimed |
| CN-115484948-A | Compound and use thereof | 福宏治疗公司 | 2022-12-16 | — | — | CN | claimed |
| EP-4096657-A1 | COMPOUNDS AND USES THEREOF | Foghorn Therapeutics Inc. (US) | 2022-12-07 | — | — | EP | claimed |
| US-20050245555-A1 | Tri-substituted ureas as cytokine inhibitors | THE PROCTER & GAMBLE COMPANY (US) | 2005-11-03 | — | — | US | claimed |
| EP-1299361-A1 | PYRAZOLE DERIVATIVES | Pfizer Limited (GB) | 2003-04-09 | — | — | EP | claimed |
| WO-2002004424-A9 | PYRAZOLE DERIVATIVES | PFIZER LTD (GB) | 2002-12-12 | — | — | WO | claimed |
| US-6410166-B1 | Organic electroluminescence device doping device and organic electroluminescence device | FUTABA CORPORATION (JP) | 2002-06-25 | — | — | US | claimed |
| US-20020032184-A1 | Pyrazole derivatives | PFIZER INC. | 2002-03-14 | — | — | US | claimed |
| WO-2002004424-A1 | PYRAZOLE DERIVATIVES | PFIZER LIMITED (GB) | 2002-01-17 | — | — | WO | claimed |
| EP-0376883-B1 | ENANTIOMERIC SILANES, MODIFIED SUPPORT AND ITS USE | CIBA-GEIGY AG (CH) | 1993-04-07 | — | — | EP | claimed |
| US-4997966-A | Chromatography, chemical condensation | CIBA-GEIGY CORPORATION (US) | 1991-03-05 | — | — | US | claimed |
| EP-0376883-A1 | Enantiomeric silanes, modified support and its use | CIBA-GEIGY AG (CH) | 1990-07-04 | — | — | EP | claimed |
| US-4073783-A | PENICILLINS | PFIZER INC. (US) | 1978-02-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050245555-A1 | Tri-substituted ureas as cytokine inhibitors | IL1B, IL1A, IL6 | TSHR 3023/4885TTR 1133/4885ALB 2030/4885 |
| US-20230149414-A1 | COMPOUNDS AND USES THEREOF | VHL, CLN6, TFEB | TSHR 4351/4885TTR 3059/4885ALB 4644/4885 |
| US-20230348432-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | CYP4F3, CYP4X1, GLRX3 | TSHR 139/4885TTR 2302/4885ALB 4313/4885 |
| US-20230295162-A1 | SYNTHESIS OF NOVEL IMIPRIDONE DERIVATIVES AND THEIR EVALUATION FOR THEIR ANTICANCER ACTIVITY | IMPA1, REN, IGF1R | TSHR 1686/4885TTR 3033/4885ALB 4363/4885 |
| US-20020032184-A1 | Pyrazole derivatives | POLRMT, TPMT, CYP3A43 | TSHR 2816/4885TTR 371/4885ALB 3329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.